HGH 10iu

What is HGH (10 IU)?

Human growth hormone (HGH), also known as somatotropin, is a naturally occurring peptide hormone produced by the anterior pituitary gland and plays a role in regulating growth, metabolism, and cellular signaling.

In research settings, peptide fragments derived from growth hormone are used to investigate structure–function relationships, receptor-binding regions, and localized biological activity within the broader hormone molecule. Studying shorter fragments allows researchers to isolate specific amino acid sequences and evaluate how individual regions contribute to receptor interaction, intracellular signaling, or protein stability. This targeted approach supports mechanistic research without relying on the complete hormone structure.

Product Specifications

• Category: Peptides
• Subcategory: Muscle Growth & Performance Peptides
• Peptide Sequence: H-Glu-Glu-Ala-Tyr-Ile-Pro-Lys-OH
• Synonym: Somatotropin (32–38) / HGH (32–38)
• Molecular Formula: C₃₉H₆₀N₈O₁₃
• Molecular weight: 848.9 g/mol
• Purity: ≥95% (verified by HPLC and mass spectrometry)
• Packaging Format: 10 IU lyophilized powder in a sealed research-grade vial
• Storage Conditions: Store at −20 °C; protect from light and moisture
• Intended Use: For Laboratory Research Use Only

Key Characteristics of HGH (10 IU)

• Synthetic peptide fragment corresponding to a defined region of the somatotropin molecule.
• Designed for controlled laboratory investigation of growth hormone–related mechanisms.
• Enables targeted evaluation of specific amino acid sequences within the HGH structure.
• Lyophilized formulation enhances long-term stability and handling consistency.
• Analytical verification typically performed using HPLC and mass spectrometry.
• Suitable for biochemical, receptor-binding, and molecular modeling research.

How HGH (10 IU) Supports Research

HGH-related peptide fragments are used in laboratory research to better understand how growth hormone interacts with its receptor and activates intracellular signaling pathways. By isolating a short region of the full hormone, researchers can study how specific residues influence receptor recognition, protein folding, and downstream molecular responses.

This fragment-based approach is particularly useful in structure–activity research, where investigators compare full-length growth hormone with truncated or modified sequences. Typical experimental applications include mapping putative receptor-contact motifs, testing fragment binding in ligand–receptor or peptide–protein interaction assays, and using the fragment as a control or comparison sequence in structure–activity studies.

Any observed biological activity of this fragment is highly model-dependent and is not equivalent to the full spectrum of actions associated with intact human growth hormone. Such studies contribute to broader knowledge of endocrine regulation, protein–protein interactions, and signal transduction mechanisms in controlled experimental systems. All findings remain investigational and confined to laboratory models.

Research Applications & Usage Information

HGH (10 IU) peptide fragment is commonly incorporated into research involving:

• Growth hormone receptor interaction studies
• Structure–activity and structure–function analysis
• Protein-binding and affinity assays
• Endocrine signaling pathway modeling
• Comparative analysis of somatotropin fragments vs. full-length hormone
• Biochemical characterization and molecular modeling experiments

All applications are conducted in controlled laboratory or preclinical research environments.

Handling and Storage Recommendations

• Store unopened vials at −20°C; short‑term storage at 2–8°C is acceptable.
• Protect from light, excessive heat, and humidity.
• After reconstitution, store at 2–8°C and use within protocol‑defined laboratory timeframes.
• Avoid repeated freeze–thaw cycles to preserve peptide integrity.
• Follow institutional laboratory safety and handling procedures.

Proper storage and careful handling help maintain peptide integrity and ensure reliable experimental outcomes.

Research Use Only Notice

This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.

References

1. National Center for Biotechnology Information. PubChem compound summary for CID 126658, Somatotropin (32‑38). PubChem. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/126658
2. Sami AJ. Structure-function relation of somatotropin with reference to molecular modeling. Curr Protein Pept Sci. 2007;8(3):283-292. doi:10.2174/138920307780831820
3. Fernández-Garza LE, Guillen-Silva F, Sotelo-Ibarra MA, Domínguez-Mendoza AE, Barrera-Barrera SA, Barrera-Saldaña HA. Growth hormone and aging: a clinical review. Frontiers in Aging. 2025;6:1549453. doi:10.3389/fragi.2025.1549453
4. Somatropin for growth hormone deficiency. In: CADTH Canadian Drug Expert Committee Reports. Ottawa, ON: Canadian Agency for Drugs and Technologies in Health; 2023. https://www.ncbi.nlm.nih.gov/books/NBK596750/